Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced that the European Commission (EC) granted marketing authorisation in the ...
in.investing.com on MSN1d
Biocon Gets EU Nod for Ustekinumab Biosimilar; Valuation Signals UpsideFor investors eyeing Biocon’s stock, this approval could be a significant catalyst. According to InvestingPro’s fair value ...
Female Entrepreneurs are making a great impact in India. Here’s a list of India’s most influential women entrepreneurs who ...
The Nifty Pharma index closed on a negative note on Tuesday. Shares of Ajanta Pharma Ltd.(up 3.6 per cent), Abbott India Ltd.
AM(IST)on Tuesday in a weak market. Abbott India Ltd.(up 0.47 per cent) and Glenmark Pharmaceuticals Ltd.(up 0.44 per cent) ...
The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...
Biocon Ltd share price was down by -2.77% from the previous closing price of ₹359.30. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...
Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback